Year |
Author |
Country of the study |
Number of patients (PCI) |
Success rate, % |
Complications, % |
May 2017 |
Kiemeneij [5] |
Netherlands |
70 (25) |
89 |
dRAO: 1.5% |
Jul 2017 |
Amin et al. [15] |
Bangladesh |
50 |
98 |
No complications observed |
Jan 2018 |
Roghani-Dehkordi et al. [16] |
Iran |
235 |
94 |
No complications observed |
Mar 2018 |
Al-Azizi and Lotfi [17] |
US |
22 (7) |
100 |
No complications observed |
Mar 2018 |
Valsecchi et al. [18] |
Italy |
52 (25) |
90 |
pRAO: 4%, artery spasm: 2% |
Mar 2018 |
Soydan and Akin [19] |
Turkey |
54 (20) |
96.3 |
Artery spasm: 3.7% |
Aug 2018 |
Coughlan et al. [20] |
Ireland |
47 |
100 |
No complications observed |
Aug 2018 |
Kim et al. [21] |
Korea |
150 (42) |
88 |
Hematoma: 4.9% |
Sep 2018 |
Koutouzis et al. [22] |
Greece |
100 |
70 |
No complications observed |
Oct 2018 |
Ziakas et al. [23] |
Greece |
49 (8) |
90 |
Hematoma: 16%, bleeding: 4.5%, artery spasm: 16%, pain: 9%, |
Dec 2018 |
Wretowski et al. [24] |
Poland |
218 (48) |
89.4 |
No complications observed |
Feb 2019 |
Aoi et al. [25] |
US |
202 (90) |
99.5 |
Hematoma: 10.1%, dRAO: 1.0%, arteriovenous fistula: 0.5% |
Mar 2019 |
Maitra et al. [26] |
India |
55 |
87.3 |
Hematoma 2% |
Apr 2019 |
Norimatsu et al. [10] |
Japan |
74 (27) |
91 |
No complications observed |
May 2019 |
Gasparini et al. [27] |
Italy |
41(41) |
82.9 |
Artery spasm: 10%, dRAO: 2.4% |
May 2019 |
Mizuguchi et al. [28] |
Japan |
228 (77) |
99.5 |
Hematoma: 4.4%, pRAO: 0.4%, dRAO: 3.1%, numbness: 0.9% |
Jul 2019 |
Vefali et al. [13] |
Turkey |
102 (24) |
95.1 |
No complications observed |
Sep 2019 |
Lee et al. [29] |
Korea |
200 (86) |
95.5 |
Hematoma: 7.4%, arterial dissection: 0.5%, numbness: 1% |
Dec 2019 |
Aqel et al. [30] |
Palestine |
200 (17) |
98 |
No complications observed |